Variant report
Variant | nsv970117 |
---|---|
Chromosome Location | chr6:44945572-44946769 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201245844 | chr6:44945582-44945583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527647030 | chr6:44945583-44945584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558843670 | chr6:44945623-44945624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552948424 | chr6:44945650-44945651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9463056 | chr6:44945680-44945681 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs9472413 | chr6:44945717-44945718 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs186027639 | chr6:44945749-44945750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369910312 | chr6:44945822-44945823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568610482 | chr6:44945885-44945886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189795782 | chr6:44945907-44945908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548226990 | chr6:44945910-44945911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574474208 | chr6:44945980-44945981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150254029 | chr6:44946000-44946001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558453365 | chr6:44946019-44946020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576712020 | chr6:44946046-44946047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181387313 | chr6:44946103-44946104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138890803 | chr6:44946109-44946110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574530537 | chr6:44946131-44946132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541970956 | chr6:44946145-44946146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374634648 | chr6:44946172-44946173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572498277 | chr6:44946231-44946232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186958616 | chr6:44946239-44946240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143152390 | chr6:44946251-44946252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532063520 | chr6:44946252-44946253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544081270 | chr6:44946296-44946297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562152850 | chr6:44946303-44946304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529479502 | chr6:44946323-44946324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112798082 | chr6:44946327-44946328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566541350 | chr6:44946402-44946403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190663489 | chr6:44946407-44946408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143808311 | chr6:44946445-44946446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2396369 | chr6:44946463-44946464 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs2396370 | chr6:44946472-44946473 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs556246096 | chr6:44946481-44946482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9472414 | chr6:44946506-44946507 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
36 | rs182922247 | chr6:44946538-44946539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2396371 | chr6:44946550-44946551 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs75600529 | chr6:44946578-44946579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186140675 | chr6:44946589-44946590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144629263 | chr6:44946626-44946627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546290425 | chr6:44946672-44946673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530515477 | chr6:44946731-44946732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190950641 | chr6:44946732-44946733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529022467 | chr6:44946733-44946734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114175909 | chr6:44946747-44946748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16790693 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chordoma | 18071362 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Ovarian cancer | 20844748 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:44939800-44951200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:44940800-44957000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr6:44941600-44947000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
4 | chr6:44942200-44946400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
5 | chr6:44942200-44947000 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
6 | chr6:44942400-44946600 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
7 | chr6:44942400-44946800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
8 | chr6:44942800-44946800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
9 | chr6:44943000-44947000 | Weak transcription | Fetal Heart | heart |
10 | chr6:44943400-44946600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
11 | chr6:44943400-44946600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
12 | chr6:44943400-44946600 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
13 | chr6:44943600-44946000 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
14 | chr6:44943800-44946200 | Enhancers | Dnd41 | blood |
15 | chr6:44945000-44946600 | Enhancers | Primary T cells from cord blood | blood |
16 | chr6:44945200-44946000 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
17 | chr6:44946400-44946600 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
18 | chr6:44946600-44955000 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
19 | chr6:44946600-44955000 | Weak transcription | Primary T helper cells fromperipheralblood | blood |